With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act (P.L. 118-66), which was signed into law on July 2, 2024.
Diabetes and weight loss drug advertising tops $1B on strength of GLP-1 brand spending
The new class of GLP-1 drug brands is driving diabetes and weight loss prescription drug advertising spending, pushing the combined category to more than $1